Last month, FDA also approved Praluent label update for some patients currently requiring LDL apheresis therapy
PR Newswire
TARRYTOWN, N.Y. and PARIS, Sept. 12, 2018
PR Newswire
TARRYTOWN, N.Y. and PARIS, Sept. 12, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey